Scientists at Cognigenics have made a significant advance in the field of neuroscience and mental health treatment. Their groundbreaking research, published in Genomic Psychiatry, demonstrates that a new RNA-based therapy called COG-201 can enhance memory and reduce anxiety in animal models.
FDA approves decade-old Pfizer drug for rare childhood leukemia
A Pfizer leukemia drug that has been approved in adults for more than a decade will soon be available for kids 1 year and older.